These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Outpatient dobutamine for refractory congestive heart failure: advantages, techniques, and results. Miller LW J Heart Lung Transplant; 1991; 10(3):482-7. PubMed ID: 1854777 [TBL] [Abstract][Full Text] [Related]
5. The value of intermittent inotropic therapy in unhospitalized patients with refractory heart failure. Moga VD; Luca C; Luca CT; Branea H; Drăgulescu SI Rom J Intern Med; 1999; 37(1):25-9. PubMed ID: 15523942 [TBL] [Abstract][Full Text] [Related]
6. [Intermittent infusions of dobutamine in the treatment of chronic cardiac failure in the terminal stage]. Marcon JL; Bonijoly S; Favre E Ann Cardiol Angeiol (Paris); 1993 Nov; 42(9):495-502. PubMed ID: 8122866 [TBL] [Abstract][Full Text] [Related]
7. Outpatient use of dobutamine to support patients awaiting heart transplantation. Miller LW; Merkle EJ; Jennison SH J Heart Lung Transplant; 1994; 13(4):S126-9. PubMed ID: 7947869 [No Abstract] [Full Text] [Related]
9. Dobutamine effects on spontaneous variability of ventricular arrhythmias in patients with severe chronic heart failure: the Italian Multicenter Study. Puddu PE; Papalia U; Schiariti M; Usta C; Ital Heart J; 2004 Sep; 5(9):693-701. PubMed ID: 15568599 [TBL] [Abstract][Full Text] [Related]
10. Home continuous positive inotropic infusion as a bridge to cardiac transplantation in patients with end-stage heart failure. Upadya S; Lee FA; Saldarriaga C; Verma S; Sedrakyan A; Nystrom K; Katz SD J Heart Lung Transplant; 2004 Apr; 23(4):466-72. PubMed ID: 15063407 [TBL] [Abstract][Full Text] [Related]
11. Outpatient dobutamine and dopamine infusions in the management of chronic heart failure: clinical experience in 21 patients. Applefeld MM; Newman KA; Sutton FJ; Reed WP; Roffman DS; Talesnick BS; Grove WR Am Heart J; 1987 Sep; 114(3):589-95. PubMed ID: 3630900 [TBL] [Abstract][Full Text] [Related]
12. Reverse left ventricular remodeling by intermittent dobutamine infusions and amiodarone in end-stage heart failure due to idiopathic dilated cardiomyopathy. Nanas JN; Tsagalou EP; Nanas SN; Terrovitis JV; Tsolakis EJ; Toumanidis S; Papazoglou PD; Alexopoulos GP; Kanakakis J; Anastasiou-Nana MI Int J Cardiol; 2006 Apr; 108(2):237-43. PubMed ID: 16183152 [TBL] [Abstract][Full Text] [Related]
13. [Dobutamine therapy at home under the guidance of a nurse practitioner, either as a bridge to cardiac transplantation or as destination therapy in severe heart failure]. Brügemann J; de Jonge-Weber AT; Rienstra M; van den Broek SA; Zijlstra F; van Veldhuisen DJ Ned Tijdschr Geneeskd; 2007 Nov; 151(44):2460-5. PubMed ID: 18064867 [TBL] [Abstract][Full Text] [Related]
15. Hemodynamic effects of levosimendan added to dobutamine in patients with decompensated advanced heart failure refractory to dobutamine alone. Nanas JN; Papazoglou PP; Terrovitis JV; Kanakakis J; Dalianis A; Tsolakis E; Tsagalou EP; Agrios N; Christodoulou K; Anastasiou-Nana MI Am J Cardiol; 2004 Nov; 94(10):1329-32. PubMed ID: 15541261 [TBL] [Abstract][Full Text] [Related]
16. [Short-term dobutamine therapy in severe cardiac insufficiency]. Weiss P; Schmidlin O; Ha HR; Ritz R; Follath F Schweiz Med Wochenschr; 1990 Feb; 120(6):190-3. PubMed ID: 2305231 [TBL] [Abstract][Full Text] [Related]
17. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects. Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669 [TBL] [Abstract][Full Text] [Related]
18. Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure. Herweg B; Ilercil A; Cutro R; Dewhurst R; Krishnan S; Weston M; Barold SS Am J Cardiol; 2007 Jul; 100(1):90-3. PubMed ID: 17599447 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of intermittent, long-term, concomitant dobutamine and levosimendan infusions in severe heart failure refractory to dobutamine alone. Nanas JN; Papazoglou P; Tsagalou EP; Ntalianis A; Tsolakis E; Terrovitis JV; Kanakakis J; Nanas SN; Alexopoulos GP; Anastasiou-Nana MI Am J Cardiol; 2005 Mar; 95(6):768-71. PubMed ID: 15757608 [TBL] [Abstract][Full Text] [Related]
20. [The dobutamine-dopamine combination versus amrinone in congestive heart failure with a marked edematogenic sign complicated by functional kidney failure. A comparison between 2 different models of inotropic stimulation and diuresis potentiation]. De Vecchis R; Pucciarelli G; Nocerino L; Cocozza M; Setaro A; Torre G; Imperatore F Minerva Cardioangiol; 1998 May; 46(5):163-74. PubMed ID: 9842199 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]